Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer

被引:47
作者
Ananthanarayanan, V
Deaton, RJ
Yang, XMJ
Pins, MR
Gann, PH [1 ]
机构
[1] Univ Illinois, Dept Pathol, Chicago, IL 60680 USA
[2] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.1186/1471-2407-6-73
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Molecular markers identifying alterations in proliferation and apoptotic pathways could be particularly important in characterizing high-risk normal or pre-neoplastic tissue. We evaluated the following markers: Ki67, Minichromosome Maintenance Protein-2 (Mcm-2), activated caspase-3 (a-casp3) and Bcl-2 to determine if they showed differential expression across progressive degrees of intraepithelial neoplasia and cancer in the prostate. To identify field effects, we also evaluated whether high-risk expression patterns in normal tissue were more common in prostates containing cancer compared to those without cancer ( supernormal), and in histologically normal glands adjacent to a cancer focus as opposed to equivalent glands that were more distant. Methods: The aforementioned markers were studied in 13 radical prostatectomy ( RP) and 6 cystoprostatectomy (CP) specimens. Tissue compartments representing normal, low grade prostatic intraepithelial neoplasia (LGPIN), high grade prostatic intraepithelial neoplasia (HGPIN), as well as different grades of cancer were mapped on H&E slides and adjacent sections were analyzed using immunohistochemistry. Normal glands within 1 mm distance of a tumor focus and glands beyond 5 mm were considered "near" and "far", respectively. Randomly selected nuclei and 40 x fields were scored by a single observer; basal and luminal epithelial layers were scored separately. Results: Both Ki-67 and Mcm-2 showed an upward trend from normal tissue through HGPIN and cancer with a shift in proliferation from basal to luminal compartment. Activated caspase-3 showed a significant decrease in HGPIN and cancer compartments. Supernormal glands had significantly lower proliferation indices and higher a-casp3 expression compared to normal glands. "Near" normal glands had higher Mcm-2 indices compared to "far" glands; however, they also had higher a-casp3 expression. Bcl-2, which varied minimally in normal tissue, did not show any trend across compartments or evidence for field effects. Conclusion: These results demonstrate that proliferation and apoptosis are altered not only in preneoplastic lesions but also in apparently normal looking epithelium associated with cancer. Luminal cell expression of Mcm-2 appears to be particularly promising as a marker of high-risk normal epithelium. The role of apoptotic markers such as activated caspase-3 is more complex, and might depend on the proliferation status of the tissue in question.
引用
收藏
页数:9
相关论文
共 56 条
[1]  
ANANTHANARAYANA.V, 2004, PROSTATE
[2]   High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence [J].
Ayala, G ;
Thompson, T ;
Yang, G ;
Frolov, A ;
Li, RL ;
Scardino, P ;
Ohori, M ;
Wheeler, T ;
Harper, W .
CLINICAL CANCER RESEARCH, 2004, 10 (19) :6572-6578
[3]   Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia [J].
Baltaci, S ;
Orhan, D ;
Özer, G ;
Tolunay, Ö ;
Gögüs, O .
BJU INTERNATIONAL, 2000, 85 (01) :155-159
[4]   Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco [J].
Barsky, SH ;
Roth, MD ;
Kleerup, EC ;
Simmons, M ;
Tashkin, DP .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (16) :1198-1205
[5]  
Bartels PH, 1998, ANAL QUANT CYTOL, V20, P397
[6]   DIFFERENTIAL EXPRESSION OF THE PS2 PROTEIN IN THE HUMAN PROSTATE AND PROSTATE-CANCER - ASSOCIATION WITH PREMALIGNANT CHANGES AND NEUROENDOCRINE DIFFERENTIATION [J].
BONKHOFF, H ;
STEIN, U ;
WELTER, C ;
REMBERGER, K .
HUMAN PATHOLOGY, 1995, 26 (08) :824-828
[7]   Human prostate cancer risk factors [J].
Bostwick, DG ;
Burke, HB ;
Djakiew, D ;
Euling, S ;
Ho, SM ;
Landolph, J ;
Morrison, H ;
Sonawane, B ;
Shifflett, T ;
Waters, DJ ;
Timms, B .
CANCER, 2004, 101 (10) :2371-2490
[8]   Expanding fields of genetically altered cells in head and neck squamous carcinogenesis [J].
Braakhuis, BJM ;
Leemans, CR ;
Brakenhoff, RH .
SEMINARS IN CANCER BIOLOGY, 2005, 15 (02) :113-120
[9]  
Braakhuis BJM, 2003, CANCER RES, V63, P1727
[10]   Ki67 protein: the immaculate deception? [J].
Brown, DC ;
Gatter, KC .
HISTOPATHOLOGY, 2002, 40 (01) :2-11